Here are some key findings: Within six months of starting GLP-1 therapy, the rate of hypotensive events increased from 8.7% to 10.2% The increased risk remained significant at 12 months, with hypotensive events rising from 13.6% to 14.3% Adults age 65 and older accounted for 53% of hypotensive events despite representing 37% of the study population Patients with Type 2 diabetes made up 75% of those experiencing hypotensive episodes but only 63% of the overall cohort In secondary analyses, the scientists found that weight loss alone did not explain the increased risk, suggesting other mechanisms of action may be at play Northwestern Now posed five questions to the study senior author Dr
Are these injections
Reconstitute lyophilized Epithalon using bacteriostatic water
Like Lexapro, Wellbutrin also has some evidence of improving attention and impulse control in certain populations, although this is not yet an FDA-approved usage
Hick, Steffen Reedtz-Runge, Tine Glendorf, Borja Ballarn-Gonzlez, Kirsten Raun, Charles Bayly-Jones, Denise Wootten & Patrick M